semaglutide 50 mg Oral taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial such as those who are obese or have weight Obesity | Novo Nordisk U.S.
Pay in 4 interest-free payments of $6.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



























